ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,849Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 2456

$822K Total Retail Price of All Prescriptions

Rank: 71 out of 2456

468 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 468 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 16,233 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,218 1,208 1 9
CITALOPRAM HBR 691 691 2 14
FUROSEMIDE 649 649 3 8
LEVOTHYROXINE SODIUM 574 561 4 4
MIRTAZAPINE 553 548 5 29
LISINOPRIL 486 454 6 1
TRAZODONE HCL 423 421 7 17
METOPROLOL TARTRATE 404 404 8 10
POTASSIUM CHLORIDE 377 370 9 33
QUETIAPINE FUMARATE 375 367 10 47
DONEPEZIL HCL 370 370 11 23
OMEPRAZOLE 341 309 12 3
SIMVASTATIN 335 303 13 2
AMLODIPINE BESYLATE 329 316 14 5
METOPROLOL SUCCINATE 313 300 15 13
ATENOLOL 279 267 16 6
PREDNISONE 261 257 17 39
NAMENDA 253 253 18 42
SEROQUEL 218 213 19 102
GABAPENTIN 184 167 20 16
HYDROCHLOROTHIAZIDE 173 160 21 7
OLANZAPINE 168 138 22 57
METHADONE HCL 164 164 S2 23 135
CARBIDOPA-LEVODOPA 164 164 23 82
TAMSULOSIN HCL 159 159 25 32
GLIPIZIDE 158 154 26 46
DIVALPROEX SODIUM 157 157 27 51
DIGOXIN 148 136 28 49
RISPERIDONE 147 130 29 50
METFORMIN HCL 137 119 30 11
IPRATROPIUM-ALBUTEROL 136 135 31 85
LIDODERM 128 128 32 58
FLUOXETINE HCL 122 99 33 45
LANTUS 119 105 34 44
TORSEMIDE 119 119 34 146
HYDROCODONE-ACETAMINOPHEN 118 118 S3 36 20
CLOPIDOGREL 108 108 37 55
FLUTICASONE PROPIONATE 105 99 38 30
DIOVAN 97 84 39 26
ALENDRONATE SODIUM 94 94 40 19
ADVAIR DISKUS 94 92 40 36
OXYCODONE HCL 92 87 S2 42 38
NYSTOP 87 73 43 125
RANITIDINE HCL 81 71 44 31
POLYETHYLENE GLYCOL 3350 81 66 44 64
KLOR-CON M20 80 63 46 69
PLAVIX 78 78 47 79
AZITHROMYCIN 77 77 48 60
FINASTERIDE 75 75 49 66
SERTRALINE HCL 73 73 50 21
ESCITALOPRAM OXALATE 68 68 51 116
ATORVASTATIN CALCIUM 68 68 51 12
ISOSORBIDE MONONITRATE ER 68 68 51 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 67 54 147
ALLOPURINOL 65 56 55 27
LOSARTAN POTASSIUM 65 65 55 18
LEVETIRACETAM 64 63 57 90
LEVOXYL 61 61 58 97
CARVEDILOL 60 60 59 54
LEVOFLOXACIN 60 58 59 103
ABILIFY 58 46 61 95
CYMBALTA 56 56 62 65
TAMIFLU 54 54 63 217
TRAMADOL HCL 53 53 64 24
VANCOMYCIN HCL 51 51 65 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.